Author MStranslate

As magnetic resonance imaging (MRI) plays a key role in the diagnosis of multiple sclerosis, we took the opportunity to ask Professor Roger Ordidge, Chair of Imaging Science at The University of Melbourne,...

Optic neuritis (inflammation of the optic nerve, (ON)) causes visual loss and is a common early symptom of multiple sclerosis (MS). Patients with ON present to hospital early and identifying measurements of...

Optic neuritis (inflammation of the optic nerve) is a common side-effect of multiple sclerosis (MS) and leads to many sight-related difficulties, including blurriness, impaired colour recognition and problems...

Filmed during our MSBase Feature Week, this short video with Associate Professor Helmut Butzkueven introduces PrevANZ, a Multiple Sclerosis Research Australia led study investigating the role Vitamin D...

Dr Vilija Jokubaitis et al Natalizumab (Tysabri) is an antibody used for the treatment of multiple sclerosis (MS). It is currently the strongest drug available for the treatment of MS, however, it has also...

MSBase is an international multiple sclerosis (MS) registry that is helping answer many questions about MS. In this short video, Associate Professor Helmut Butzkueven (neurologist, MS researcher) explains...

Dr Tomas Kalincik et al Relapses of MS activity present with worsening of neurological symptoms and are usually followed by periods of stability. These are a defining feature of relapsing-remitting MS, the...

MStranslate is excited to announce a new collaboration with the Melbourne Brain Centre at Royal Melbourne Hospital (MBC@RMH).  This opportunity follows MStranslate's presentation to the Melbourne Brain...

The first Google Hangout gave members of our community an opportunity to chat with MS researcher and MStranslate co-founder, Brett...

By Brett Drummond Recently, we had a member of our community ask us whether there was a link between Type 1 diabetes (T1D) and MS. In response, here is a short summary of what is currently known on the...